🇺🇸 Fluvastatine in United States
53 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 53
Most-reported reactions
- Acute Kidney Injury — 7 reports (13.21%)
- Diarrhoea — 6 reports (11.32%)
- Pancreatitis — 6 reports (11.32%)
- Acute Generalised Exanthematous Pustulosis — 5 reports (9.43%)
- Haematoma — 5 reports (9.43%)
- Lactic Acidosis — 5 reports (9.43%)
- Pancreatitis Acute — 5 reports (9.43%)
- Pancytopenia — 5 reports (9.43%)
- Thrombocytopenia — 5 reports (9.43%)
- Abdominal Pain — 4 reports (7.55%)
Other Other approved in United States
Frequently asked questions
Is Fluvastatine approved in United States?
Fluvastatine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fluvastatine in United States?
Centre Oscar Lambret is the originator. The local marketing authorisation holder may differ — check the official source linked above.